StonvexLoading…
StonvexStonvexStonvexCore line items from PH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $19.85B | $19.93B | $19.07B | $15.86B |
Operating Income | $4.35B | $4.07B | $3.40B | $2.98B |
Net Income | $3.53B | $2.84B | $2.08B | $1.32B |
EPS (Diluted) | $27.12 | $21.84 | $16.04 | $10.09 |
Total Assets | $29.49B | $29.30B | $29.96B | $25.94B |
Total Liabilities | $15.80B | $17.22B | $19.63B | $17.08B |
Cash & Equivalents | $467.00M | $422.00M | $475.18M | $535.80M |
Free Cash Flow OCF − CapEx | $3.34B | $2.98B | $2.60B | $2.21B |
Shares Outstanding | 130.20M | 130.20M | 129.90M | 130.36M |